Rational design reveals effective larvicides against Aedes aegypti with low toxicity to Artemia salina, suggesting new strategies for dengue control.
Aedes aegypti, the main transmitter of arboviruses responsible for several arboviruses, such as dengue, is highly prevalent in Latin America, especially in Brazil. Controlling this vector is urgent for public health, since it is more advantageous to prevent than to treat the diseases it causes. The use of chemical control methods, such as larvicides, is strategic. In this sense, the search for environmentally safer larvicides has driven the development of compounds with activity against Ae. aegypti and low toxicity to nontarget organisms. In this study, a rational design of ten 4-alkoxy/amino-7-chloroquinolines was carried out to investigate their larvicidal and toxic properties, from prediction to in vitro assays. Larvicidal tests revealed seven bioactives against Ae. aegypti (LC50 ≤ 69.18 ppm), of which compound 3 was very active (LC50 = 2.51 ppm) and compound 6′ was very highly active (LC50 = 0.02 ppm), surpassing the standard larvicide Spinosad (LC50 = 0.05 ppm). Structural analysis indicated that the −O–pentyl and −O–ethyl–Cl moieties at the 4-position of 7-chloroquinolines improved larvicidal activity when compared to 4,7-dichloroquinoline. Regarding the in vitro ecotoxicity study, bioactives 1, 6′, 7′, and 9′ showed moderate toxicity on Artemia salina larvae (LC50 = 101.68–314.58 μg·mL–1). The best results demonstrated that compound 6′, potentially nonmutagenic, nonhepatotoxic, and predicted not to cause skin sensitization, was 15 729 times more toxic to Ae. aegypti than to the nontarget organism A. salina, emerging as a safer larvicide.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: